Are ORMDL3 rs7216389 TT, IL4RA rs1801275 AG, and FCER1A rs2251746 CT linked to Th2-skewed allergic airway susceptibility?

Clinical and genetic evidence

• ORMDL3 rs7216389 TT: This homozygous risk genotype is a highly reproducible genetic risk factor for childhood-onset asthma, operating as a strong expression quantitative trait locus (eQTL) that drives elevated ORMDL3 expression in lung and immune tissues.
• IL4RA rs1801275 AG: This variant encodes the functional Q576R gain-of-function substitution in the IL-4Rα cytoplasmic tail, directly promoting systemic Th2 skewing, elevated IgE, and increased susceptibility to severe allergic airway inflammation.
• FCER1A rs2251746 CT: This functional promoter polymorphism strongly dictates basal serum IgE levels and allergic sensitization across cohort studies, modifying Th2-associated phenotypes indirectly via receptor-expression feedback loops rather than acting as an independent clinical asthma risk factor.

Mechanistic explanations

• Pathway disruption: Increased ORMDL3 expression suppresses serine palmitoyltransferase activity, disrupting sphingolipid homeostasis. This alteration drives endoplasmic reticulum stress, epithelial barrier dysfunction, and airway remodeling.
• Intracellular cascades: The IL4RA Q576R variant alters signaling downstream of the receptor; it creates a GRB2 docking site to activate MAP kinase pathways, promoting IgE production and upregulating $Fc\varepsilon{RI}$ expression.
• Transcription and receptor feedback: The FCER1A rs2251746 variant alters GATA-1 transcription factor binding to directly modulate the transcription and cell-surface abundance of the high-affinity IgE receptor $\alpha$-chain ($Fc\varepsilon{RI}\alpha$).
• Mast-cell activation: While ORMDL3 serves as a negative regulator of $Fc\varepsilon{RI}$-mediated mast-cell activation via the ATF6-UPR-autophagy pathway, the IL4RA and FCER1A variants alter receptor expression thresholds and prime the local tissue milieu, plausibly lowering the threshold for mast-cell degranulation.

Bottom line

• These three genetic variants establish a highly plausible network that drives Th2-skewed airway susceptibility, alters IgE signaling homeostasis, and primes mast cells for activation through distinct but complementary epithelial, cytokine receptor, and immunoglobulin receptor pathways.